Results 11 to 20 of about 4,911,045 (202)
Therapeutics and Clinical Risk Management, 2018 Vibhash D Sharma, Kelly E Lyons, Rajesh Pahwa Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA Abstract: Levodopa-induced dyskinesia (LID) is a common motor complication in patients with Parkinson’s disease on ...
Sharma VD, Lyons KE, Pahwa R
doaj +1 more source
Drug-induced dyskinesia when taking Fluvoxamine
Неврология, нейропсихиатрия, психосоматикаDrug-induced movement disorders (DIMD) are a significant problem in clinical practice, especially in the context of the use of psychotropic drugs.
A. A. Katok +2 more
doaj +2 more sources
New insights into the mechanism of drug-induced dyskinesia
CNS Spectrums, 2012 Dyskinesia is an extrapyramidal movement disorder characterized by involuntary, repetitive, irregular motions that affect the mouth and face and/or the limbs and trunk. Tardive dyskinesia (TD) is a well-known complication of long-term treatment with antipsychotic drugs.
Loonen, Anton J. M. +1 more
openaire +3 more sources
Co‐Expression of Tardive Dyskinesia and Drug‐Induced Parkinsonism in Rats Chronically Treated With Haloperidol [PDF]
Neuropsychopharmacology ReportsAim We aimed to create a rat model of drug‐induced parkinsonism and tardive dyskinesia by chronic administration of haloperidol and examine the expression of direct and indirect pathway markers in the striatum of the model rats.
Iku Kinoshita +7 more
doaj +3 more sources
Drug-Induced Tardive Dyskinesia
International Journal of Research and Review, 2021 Drug-induced movement disorders could be classified into acute, subacute, and chronic based on the time of occurrence. Tardive dyskinesia (TD) is one of the most frequent long-term drug-induced movement disorders. Delay in treatment often caused TD to be irreversible.
Marianto Marianto +2 more
openaire +1 more source
Drug-induced dyskinesias, can they be prevented? [PDF]
Current Problems of Psychiatry, 2020 Abstract Introduction: Dyskinesia is a symptom complex in the form of involuntary, repetitive movements of lips, lower jaw, tongue, less often the trunk and limbs. Despite the use of newer drugs in treatment neuroleptics, dyskinesia has not ceased to be a clinical problem.
Romaniuk, Małgorzata +3 more
openaire +2 more sources
Failure of pyridoxine to reduce drug-induced dyskinesias [PDF]
Journal of Neurology, Neurosurgery & Psychiatry, 1970 The use of pyridoxine seems to be ineffective in reducing tardive dyskinesia.
G E, Crane, I S, Turek, A A, Kurland
openaire +2 more sources
Primary ciliary dyskinesia (Siewert's/Kartagener's syndrome): respiratory symptoms and psycho-social impact [PDF]
, 2003 Although the pathophysiological defect in primary ciliary dyskinesia (PCD; Siewert's/Kartagener's syndrome) is now well characterised, there are few studies of the impact of the condition upon health function, particularly in later life.
I Christopher McManus +14 more
core +2 more sources
Tardive dyskinesia: Prevention and newer management strategies
Annals of Indian Psychiatry, 2020 Tardive dyskinesia (TD) is a condition where we have a limited understanding of the cause and of management. The delayed-onset movements can occur due to prolonged exposure to dopamine receptor-blocking agents (DRBAs).
Sreelakshmi Vaidyanathan +1 more
doaj +1 more source
Tardive dyskinesia on clozapine: A case report
South African Journal of Psychiatry, 2009 Antipsychotic-induced tardive dyskinesia is a potentially irremediable and debilitating condition with the onset most commonly associated with the use of first-generation antipsychotics.
Laila Asmal
doaj +1 more source